Top Markets
#1 GEKKO GEKKO +51.79%
#2 ADO Protocol ADO Protocol +38.43%
#3 Helium Helium +33.04%
#4 Pons Pons +29.76%
#5 TENDIES TENDIES +25.20%
#6 Giggle Fund Giggle Fund +20.30%
#7 CZ'S Dog CZ'S Dog +19.95%
#8 龙虾 (Lobster) 龙虾 (Lobster) +19.51%
#9 o1.exchange o1.exchange +18.05%
#10 Main Street Yield Main Street Yield +17.48%
Coin of the day
GEKKO GEKKO
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Peringkat dalam Saham #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Harga Saham
$25.61
Terakhir disinkronkan: 2025-10-10
Kapitalisasi Pasar
$1.37B
Perubahan (1 hari)
0.20%
Perubahan (1 tahun)
1.55%
Negara
US
Perdagangan Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategori

Healthcare
Laba untuk Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Harrow Health, Inc. 8.625% Senior Notes due 2026, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Harrow Health, Inc. 8.625% Senior Notes due 2026 dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT